Dr. Hayman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
20 York St
Yale-New Haven Hospital
New Haven, CT 06510Phone+1 203-688-8300
Education & Training
Yale-New Haven Medical CenterResidency, Radiation Oncology, 2016 - 2020
University of South Florida College of Medicine
Certifications & Licensure
CT State Medical License 2017 - 2025- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Inductee Alpha Omega Alpha Honor Medical Society
Publications & Presentations
PubMed
- Rethinking the use of germline CHEK2 mutation as a marker for PARP inhibitor sensitivity.Thomas J Hayman
JNCI Cancer Spectrum. 2024-07-01 - 1 citationsRadioresistant Pulmonary Oligometastatic and Oligoprogressive Lesions From Nonlung Primaries: Impact of Histology and Dose-Fractionation on Local Control After Radiati...Nipun Verma, James H Laird, Nicholas S Moore, Thomas J Hayman, Nadine Housri
Advances in Radiation Oncology. 2024-06-01 - Dose-Volume Predictors of Radiation Pneumonitis After Thoracic Hypofractionated Radiation Therapy.Alexander Sasse, Patrick Oh, Nadia Saeed, Daniel X Yang, Thomas J Hayman
Practical Radiation Oncology. 2023-11-19
Press Mentions
Yale Cancer Center to Present on the Synergistic Relationship Between Intravenously-Administered SB 11285, Spring Bank's STING Agonist Development Compound, and Radiation Therapy in Cancer at the 2019 ASTRO Annual MeetingSeptember 17th, 2019
Yale Cancer Center Research Highlighted at ASTRO 2019September 17th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
